Efficacy and safety outcomes of early versus late cryoballoon ablation of atrial fibrillation - 24-months-results from the Cryo Global Registry

FUNDING ACKNOWLEDGEMENTS: Type of funding sources: Private company. Main funding source(s): Medtronic, Inc., Minneapolis, MN, USA INTRODUCTION: Increasing evidence suggests early rhythm-control therapy in atrial fibrillation (AF) results in higher freedom from atrial arrhythmia (AA) recurrence and i...

Descripción completa

Detalles Bibliográficos
Autores principales: Lawin, D, Stellbrink, C, Chun, K R J, Li, C H, Kueffer, F, Selma, J, Oh, I Y, Herzet, J, Nitta, J, Chang, T Y, Lawrenz, T
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
9.4.4 - Catheter Ablation of Arrhythmias
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10207395/
http://dx.doi.org/10.1093/europace/euad122.682

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10207395/
http://dx.doi.org/10.1093/europace/euad122.682

Ejemplares similares